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Abstract
Background: Vibrio parahaemolyticus is a food-borne pathogen causing inflammation of the gastrointestinal
epithelium. Pathogenic strains of this bacterium possess two Type III Secretion Systems (TTSS) that deliver effector
proteins into host cells. In order to better understand human host cell responses to V. parahaemolyticus, the
modulation of Mitogen Activated Protein Kinase (MAPK) activation in epithelial cells by an O3:K6 clinical isolate,
RIMD2210633, was investigated. The importance of MAPK activation for the ability of the bacterium to be cytotoxic
and to induce secretion of Interleukin-8 (IL-8) was determined.
Results: V. parahaemolyticus deployed its TTSS1 to induce activation of the JNK, p38 and ERK MAPK in human
epithelial cells. VP1680 was identified as the TTSS1 effector protein responsible for MAPK activation in Caco-2 cells
and the activation of JNK and ERK by this protein was important in induction of host cell death. V.
parahaemolyticus actively induced IL-8 secretion in a response mediated by TTSS1. A role for VP1680 and for the
ERK signalling pathway in the stimulation of IL-8 production in epithelial cells by V. parahaemolyticus was
established. Interestingly, TTSS2 inhibited IL-8 mRNA transcription at early stages of interaction between the
bacterium and the cell.
Conclusions: This study demonstrated that V. parahaemolyticus activates the three major MAPK signalling
pathways in intestinal epithelial cells in a TTSS1-dependent manner that involves the TTSS1 effector VP1680.
Furthermore VP1680 and JNK and ERK activation were needed for maximal cytotoxicity of the bacterium. It was
shown that V. parahaemolyticus is a strong inducer of IL-8 secretion and that induction reflects a balance between
the effects of TTSS1 and TTSS2. Increases in IL-8 secretion were mediated by TTSS1 and VP1680, and augmented
by ERK activation. These results shed light on the mechanisms of bacterial pathogenesis mediated by TTSS and
suggest significant roles for MAPK signalling during infection with V. parahaemolyticus.
Background
Vibrio parahaemolyticus is a gram negative, halophilic
bacterium that is found in warm marine environments,
such as the commensal microflora of shellfish [1,2]. The
bacterium is a major food-borne pathogen that causes
acute gastroenteritis following consumption of under-
cooked or raw shellfish, especially oysters. It has become
an increasingly important pathogen during the last
decade as pandemic strains have emerged, most likely
due to rising global temperatures and increased seafood
consumption [3]. Approximately 50% of all cases of
food-borne gastroenteritis in Southeast Asia are due to
V. parahaemolyticus. It is one of the major health and
economic problems in this region and the incidence of
infection is rising throughout the United States, South
America and Europe [4-8]. The bacterium infects the
human intestinal epithelium causing diarrhoea, intestinal
inflammation, abdominal cramps, nausea, vomiting,
headaches, fever, chills and in some cases even death
[8,9]. Intestinal epithelial responses to V. parahaemolyti-
cus infection include the activation of the inflammatory
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alterations in the structure and function of the tight
junction barrier and the induction of fluid and electro-
lyte secretion [10,11].
Sequencing of the genome of a pandemic strain of
V. parahaemolyticus (RIMD2210633) in 2003 revealed
the presence of two sets of genes encoding two separate
Type III Secretion Systems, named TTSS1 and TTSS2
[12]. TTSS1 is present in all V. parahaemolyticus strains
and is involved in host cell cytotoxicity, while TTSS2 is
responsible for enterotoxicity (the ability to induce fluid
accumulation in the intestine) and is predominantly
found in pathogenic strains [13-15]. More recently a
third TTSS, that is closely related to TTSS2, was identi-
fied in trh-positive pathogenic strains of V. parahaemo-
lyticus [16]. TTSS effector proteins are injected from the
cytosol of bacterium directly into the cytoplasm of the
host cell by means of a syringe-like delivery apparatus
[17]. Once inside the host cells the effector proteins
modify the activity of eukaryotic cell signalling pathways
leading to changes in host cell behaviour that favour the
colonization and persistence of bacteria in the host [18].
The Mitogen Activated Protein Kinases (MAPK) are a
group of protein serine/threonine kinases that are acti-
vated in mammalian cells in response to a variety of
extracellular stimuli and mediate signal transduction
from the cell surface to the nucleus where they can alter
the phosphorylation status of specific transcription fac-
tors [19-21]. Three major types of MAPK pathways have
been reported so far in mammalian cells [19-21]. The
ERK1/2 pathway is involved in cell proliferation and dif-
ferentiation, whereas the JNK and p38 pathways are
activated in response to stress stimuli [19-21]. The bal-
ance between factors activated by ERK, JNK and p38
determines whether the cell lives or dies [19-21]. Modi-
fication of MAPK signalling pathways by bacteria may
contribute to induction of host cell death, which is an
important feature of bacterial pathogenesis promoting
bacterial tissue colonisation [17,22-24]. V. parahaemoly-
ticus induces cell death via TTSS1 in epithelial cells and
macrophages [14,25-28]. Most recently autophagic cell
death has been implicated as the mechanism by which
V. parahaemolyticus exerts its cytotoxicity [26,29]. The
role of MAPK in the induction of autophagy and cell
death by V. parahaemolyticus has not hitherto been
investigated.
The V. parahaemolyticus VopP TTSS2 effector (also
known as VopA) has been shown to inhibit MAPK sig-
nalling pathways in macrophages. It binds directly to
MAPK kinases (MKK), the upstream kinases that phos-
phorylate the MAPK, and both prevents their activation
and inhibits their activity. This it accomplishes by acety-
lating the catalytic loop of MKK, thereby inhibiting ATP
binding [18,30]. Enteric pathogenic bacteria can elicit or
suppress expression of cytokines and chemokines from
host cells, often via modification of MAPK signalling
pathways. Interleukin 8 (IL-8) is a chemokine secreted
basolaterally by epithelial cells thus creating an IL-8 gra-
dient responsible for migration of neutrophils to the site
of infection and is a key player in the initiation of an
inflammatory response. The MAPK are involved in the
signal transduction pathways leading to IL-8 chemokine
production [31-33]. To date there are no published data
on the effect of V. parahaemolyticus i n f e c t i o no nI L - 8
expression.
Employing an in vitro model of intestinal epithelial
infection we have found that V. parahaemolyticus
induces JNK, ERK and p38 activation in human epithe-
lial cells and that the TTSS1 effector VP1680 mediates
the activation of p38 and JNK. Moreover, the MAPK
activation within the host cells is associated with the
cytotoxic effects exerted by V. parahaemolyticus and
with the induction of IL-8 secretion by the bacterium.
The diverse roles of MAPK signalling during infection
with V. parahaemolyticus indicate that the bacterium
may use more than one mechanism to sabotage normal
cellular processes and disrupt host response to infection.
Results
V. parahaemolyticus activates the MAPK signalling
pathways in intestinal epithelial cells
For several pathogenic bacteria modulation of the activ-
ity of the MAPK signalling pathway is a critical event in
their ability to colonise the host [22-24]. The role of
MAPK signalling during V. parahaemolyticus infection
and the ability of the bacteria to modulate host cell
responses via this pathway has not been elucidated so
far. The first aim of our study was to examine responses
of cell signalling MAPK to V. parahaemolyticus. Caco-2
cells were co-incubated with WT RIMD2210633 bac-
teria for 15, 60 and 120 min at an MOI of 10. Anisomy-
cin was used as a positive control to induce
phosphorylation of each of the MAPK. Heat-killed
(60°C, 20 min) WT bacteria were included to investigate
the effect of bacterial cell surface moieties on MAPK
activation, in the absence of active protein synthesis and
growth. The extracted proteins were subjected to immu-
noblotting analysis with anti-phospho-JNK, -phospho-
p38 and -phospho-ERK1/2 antibodies. The stripped
membranes were re-probed with anti-total-JNK, -p38,
-ERK1/2 antibody to detect the total level of each
MAPK protein present in the samples and to control for
loading quantities. JNK and p38 were phosphorylated in
cells co-incubated with the WT bacteria, in comparison
to samples obtained from untreated Caco-2 cells which
showed no MAPK activation (Figure 1). Strong activa-
tion of JNK and p38 was observed at the 2 h time point,
but not at earlier time points. In contrast, little or no
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Figure 1 V. parahaemolyticus induces JNK, p38 and ERK phosphorylation in intestinal epithelial cells. Caco-2 cells were co-incubated
with viable V. parahaemolyticus WT RIMD2210633 for 15, 60 or 120 min, with 50 μg/ml anisomycin for 30 min or with heat-killed WT
V. parahaemolyticus for 2 h. Cell lysates were prepared and proteins separated by SDS-PAGE. Following transfer of proteins to nitrocellulose
membranes, the membranes were probed with anti-phospho-JNK, -phospho-p38 and -phospho-ERK1/2 antibodies. The stripped membranes
were re-probed with the corresponding anti-total-MAPK antibodies to control for equivalent protein loading. A. Representative image of MAPK
immunoblot. Results are representative of at least three independent experiments. B. Quantification of MAPK activation. Results are expressed as
the ratio of phospho-MAPK to total MAPK and as relative to levels in Caco-2 cells alone. Results indicate mean ± standard error of the mean
(SEM) of three independent experiments. **P < 0.01; ***P < 0.001 vs medium.
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Page 3 of 16phosphorylation of JNK and p38 was detected in cells
incubated for 2 h with the heat-killed WT bacteria, indi-
cating that the induction of activation of these two
MAPK is an active process of V. parahaemolyticus
requiring viable bacteria. The patterns of ERK activation
in response to V. parahaemolyticus were similar with
lower phosphorylation signals detected. These studies
indicate that V. parahaemolyticus induces activation of
the JNK, p38 and ERK MAPK signalling pathways via a
mechanism requiring metabolically active bacteria.
TTSS1 of V. parahaemolyticus is responsible for activation
of JNK, p38 and ERK in epithelial cells
TTSS effectors of several pathogenic bacteria have been
shown to modify MAPK activation levels in eukaryotic
cells [24,34-36]. As V. parahaemolyticus was able to
induce phosphorylation of p38, JNK and ERK MAPK by
an active process, we next investigated the involvement
of the TTSS of V. parahaemolyticus in the activation of
these MAPK. Bacteria lacking a functional TTSS1 or a
functional TTSS2 were constructed by deleting the cor-
responding vscN gene for each secretion system. Based
on homology to other TTSS the vscN genes are pre-
sumed to encode the ATPases that power the secretion
process. Caco-2 cells were co-incubated with WT,
ΔvscN1 and ΔvscN2 V. parahaemolyticus for 2 h and
MAPK activation analysed by immunoblotting. ΔvscN2
bacteria induced similar levels of JNK phosphorylation
in Caco-2 cells as those induced by the WT bacteria,
when compared to untreated Caco-2 cells (Figure 2). In
contrast the ΔvscN1 bacteria did not cause an increase
in JNK activation, indicating that TTSS1 is required for
the induction of JNK phosphorylation in epithelial cells
by V. parahaemolyticus. Similarly, p38 was phosphory-
lated to equivalent levels in cells co-incubated with WT
and ΔvscN2 bacteria compared to cells alone. Activation
of p38 was greatly diminished when the Caco-2 cells
were incubated with ΔvscN1 bacteria showing that the
TTSS1 of V. parahaemolyticus plays an essential role in
the activation of p38 in epithelial cells in response to
infection. Conversely TTSS2 is not required for p38 or
JNK activation by V. parahaemolyticus.T h ed e g r e eo f
ERK phosphorylation was similar in cells co-incubated
with wild-type, ΔvscN1 and ΔvscN2 bacteria (Figure 2),
although in each case the increase compared to cells
alone was less than two-fold. As the increase in activa-
tion of ERK in Caco-2 cells was low, the ability of V.
parahaemolyticus to induce MAPK activation in an
alternative human epithelial cell line - HeLa - was inves-
tigated. There was a greater increase in the activation of
ERK in response to WT bacteria in this cell line as com-
pared to Caco-2 cells (Figure 2). The requirement for
TTSS1 to activate each MAPK was evidenced by the
lack of activation seen in response to the ΔvscN1 strain.
These results provide the first evidence that activation
of the JNK, p38 and ERK MAPK pathways in human
epithelial cells infected with V. parahaemolyticus
depends on the bacterium’s TTSS1.
The TTSS1-dependent cytotoxicity of V. parahaemolyticus
succeeds MAPK activation
It is well known that MAPK are activated during cellular
stress responses and that they mediate signal transduc-
tion events leading to cell death. It has previously been
demonstrated that V. parahaemolyticus induces cell
death in a TTSS1-dependent manner in a variety of cell
types, including Caco-2 cells. To determine whether
MAPK activation in the Caco-2 cells is a consequence
of the cytotoxicity of V. parahaemolyticus we investi-
gated the kinetics of cytotoxicity of the bacterium in
these epithelial cells. The Caco-2 monolayers were co-
incubated with WT, ΔvscN1 and ΔvscN2 bacteria for 1,
2, 3 or 4 h and cytotoxicity was quantified by measure-
ment of cell lysis (LDH assays) and cellular metabolism/
viability (MTT assays). After 1 and 2 h of incubation
there was no significant LDH release (Figure 3A) or
decrease in cell viability (Figure 3B) observed in any of
the samples. Following 3 h of incubation, WT and
ΔvscN2 V. parahaemolyticus induced cell lysis and
decreased cell viability of the Caco-2 cells in comparison
to untreated cells. A dramatic increase in cell lysis and
decrease in cell viability was observed in the Caco-2
cells co-incubated with the WT and ΔvscN2 bacteria at
the 4 h time point, with more than 80% cell death. In
contrast, no significant cell death was detected in sam-
ples co-incubated with the ΔvscN1 V. parahaemolyticus
or with heat-killed WT bacteria at any time point and
the levels obtained were comparable to the results
obtained for untreated Caco-2 cells. Overall the results
confirmed that TTSS1 is required for the cytotoxicity of
V. parahaemolyticus towards Caco-2 cells. The LDH
and MTT assay results mirrored one another, notwith-
standing that MTT measures changes in cell metabolism
and as such is a more sensitive reflection of cell pathol-
ogy than membrane damage. Moreover, we have shown
that V. parahaemolyticus was cytotoxic to the epithelial
cells in a time-dependent manner with no cell lysis
occurring at the 2 h time point and increasing amounts
of cell lysis at the later 3 h and 4 h time points.
These results prompted us to determine Caco-2 cell
viability using fluorochrome staining (Figure 3C). Caco-
2 cells co-incubated with WT, ΔvscN1 and ΔvscN2 bac-
teria were stained with Hoechst 33324 to visualize cell
nuclei. Propidium iodide was included in the study to
visualise dead cells that incorporate the stain due to loss
of their membrane integrity. The results revealed that
WT V. parahaemolyticus and the TTSS deletion
mutants did not affect the viability of the Caco-2 cells
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Figure 2 Activation of JNK, p38 and ERK is mediated by TTSS1.C a c o - 2a n dH e L ac e l l sw e r ec o - i n c u b a t e dw i t hV. parahaemolyticus WT
RIMD2210633, ΔvscN1, ΔvscN2 and Δvp1680 for 2 h or with anisomycin for 30 min. Immunoblotting of cell lysates was performed as described in
Figure 1. A. Representative image of MAPK immunoblot. Results are representative of at least three independent experiments. B. Quantification
of MAPK activation in Caco-2 cells. Results are expressed as the ratio of phospho-MAPK to total MAPK and as relative to levels in Caco-2 cells
alone. Results indicate mean ± SEM of three independent experiments.
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Page 5 of 16during the first 2 h of co-incubation. The cytotoxic
effect of V. parahaemolyticus infection was observed
after 4 h of incubation of the Caco-2 cells with WT and
ΔvscN2,b u tn o tΔvscN1,b a c t e r i ac o n f i r m i n gt h a t
V. parahaemolyticus cytotoxicity is TTSS1-dependent.
Next we examined the morphological changes induced
in epithelial cells by V. parahaemolyticus.F i g u r e3 D
shows the development of rounded cells after 2 h of co-
incubation of the Caco-2 cells with the WT bacteria.
After 4 h the rounded cells were still present but visible
cell loss was also observed because of the cytotoxic
effect exerted by V. parahaemolyticus, consistent with
the LDH and MTT results. Similar to WT bacteria, the
ΔvscN2 mutant induced cell rounding after 2 h of co-
incubation and cell rounding combined with significant
cell loss after 4 h. The monolayer of Caco-2 cells co-
incubated with ΔvscN1 bacteria remained intact and
exhibited the morphological features of untreated cells,
even after 4 h of co-incubation, suggesting that TTSS1
is required for monolayer disruption and cell rounding
and confirming its role in the cytotoxicity of V. para-
haemolyticus towards epithelial cells.
Together these results suggest that the cytotoxicity of
V. parahaemolyticus is TTSS1-dependent and show that
this cytotoxic effect occurs after 3 h of co-incubation.
As strong MAPK activation is observed after 2 h of
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Figure 3 TTSS-1 dependent cytotoxicity occurs later than MAPK activation. Caco-2 cells were co-incubated with viable V. parahaemolyticus
WT RIMD2210633, ΔvscN1, ΔvscN2 or with heat-killed WT V. parahaemolyticus for 1, 2, 3 and 4 h (A and B) or 2 and 4 h (C and D). Values are
presented as mean ± SEM; **P < 0.01 vs medium and vs WT. A: Cell lysis was determined by assaying LDH activity in the growth medium.
Results are one representative experiment performed in triplicate of three independent experiments. B: MTT reduction by living cells was
quantified. Results, expressed as percentage of cell viability, are one representative experiment performed in triplicate of three independent
experiments. C: Cells were stained with propidium iodide to visualize dead cells with loss of membrane integrity and with Hoechst 33342 to
show nuclei in all cells. Three hundred Caco-2 cells were scored via fluorescent microscopy. The results, expressed as percentage dead cells, are
from three independent experiments. D: Morphological changes of the Caco-2 cells were observed by phase contrast light microscope
(magnification 400×).
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Page 6 of 16co-incubation, we propose that MAPK activation is not
a consequence of cytotoxicity, but rather it might be a
prerequisite for cytotoxicity.
JNK and ERK are involved in the TTSS1-dependent
cytotoxicity of V. parahaemolyticus
As MAPK signalling pathways are involved in cell fate
determination by co-ordinately regulating a wide range
of cellular activities ranging from gene expression, meta-
bolism and motility to mitosis, survival, differentiation
a n da p o p t o s i s[ 2 0 ] ,w en e x ts o u g h tt od e t e r m i n e
whether the cytotoxicity of V. parahaemolyticus was a
result of MAPK activation by the use of MAPK inhibi-
tors. SP600125 is a reversible ATP-competitive inhibitor
of JNK that prevents the phosphorylation of JNK sub-
strates. In an analogous manner SB203580 is a specific
inhibitor of p38 by acting as a competitive inhibitor of
ATP binding. PD98059 is a selective inhibitor of MEK1
activation and the ERK cascade, as it binds to the inac-
tive forms of MEK1 and prevents activation by upstream
activators. The concentration of inhibitors that abro-
gated MAPK activity was initially determined by titra-
tion experiments with 7-day Caco-2 cells stimulated
with anisomycin. The activation levels of ERK, the p38
target MK-2 and the JNK target c-jun in cell lysates
were assessed by immunoblotting with phospho-specific
antibodies. Each MAPK inhibitor specifically reduced
the phosphorylation of its cognate indicator protein
(data not shown). To assess the importance of MAPK
activation in the cytotoxic ability of V. parahaemolyti-
cus, WT bacteria were co-incubated with Caco-2 cells in
the presence of SB203580, SP600125 or PD98059 for 4
h and then the LDH assay was performed to quantify
the level of cell lysis. The inhibitors alone did not affect
the viability of the Caco-2 cells (data not shown). The
JNK and ERK inhibitors (SP600125 and PD98059,
respectively) caused a decrease in Vibrio-induced cell
lysis of the Caco-2 cells. Cytotoxicity was reduced by
about a third by each of these inhibitors (Figure 4A). In
contrast, there was no significant difference in the level
of cell lysis that occurred in samples incubated with or
without the p38 inhibitor (SB203580). Addition of both
SP600125 and PD98059 together during the co-incuba-
tion did not decrease cytotoxicity levels below the level
seen with either inhibitor alone (data not shown). The
results suggest that activation of JNK and ERK, but not
p38, is involved in the ability of V. parahaemolyticus to
be cytotoxic to the Caco-2 cells. Recently autophagic
cell death has been implicated as the mode of TTSS1-
mediated cytotoxicity [25,29]. The effect of the MAPK
inhibitors on the induction of this process by WT V.
parahaemolyticus was assessed by visualising monodan-
sylcadaverine (MDC) accumulation in autophagic
vacuoles. Increased MDC accumulation occurred upon
co-incubation with WT bacteria (Figure 4B) and this
accumulation was less evident in the presence of the
ERK inhibitor PD98059. These results indicate that acti-
vation of ERK by V. parahaemolyticus may influence
cytotoxicity at the stage of autophagy induction, while
JNK may act at a later stage.
The TTSS1 effector VP1680 regulates MAPK activation
The results above demonstrated that TTSS1 was respon-
sible for stimulating the activation of p38 and JNK in
epithelial cells in response to V. parahaemolyticus.
Three proteins have so far been identified as TTSS1
effector proteins, namely VP1680 (also known as VopQ
and VepA), VP1686 (also known as VopS) and
VPA0450 and of these three proteins VP1680 has been
implicated in the ability of V. parahaemolyticus to be
cytotoxic to epithelial cells [25,29]. As we had shown a
link between the two TTSS1-dependent activities of
cytotoxicity and MAPK activation, the role of VP1680 in
these processes was next investigated. First a strain of
V. parahaemolyticus containing a knock-out of the
vp1680 gene was constructed. To authenticate the muta-
tion, the level of cell lysis induced by the Δvp1680 strain
was determined by the LDH assay. Over a 4 h period
the viability of the Caco-2 cells co-incubated with the
Δvp1680 strain was comparable to the viability of cells
co-incubated with the ΔvscN1 strain (at the 4 h time
point the percentage cell lysis values were: WT - 52±8%;
ΔvscN1 -1 0 ± 2 % ;Δvp1680 -8±1%) confirming that the
VP1680 TTSS1 effector protein is the principle factor
responsible for the cytotoxicity of V. parahaemolyticus
towards epithelial cells. Analysis of the morphology of
the cells co-incubated with the Δvp1680 bacteria showed
that the cells were still attached to the substratum as a
confluent monolayer, but appeared rounded and did not
display evidence of tight junctions (Additional file 1,
Figure S1). In contrast cells co-incubated with ΔvscN1
bacteria were indistinguishable from non-infected cells.
This indicated that VP1686 [37,38] was being the trans-
located into host cells by Δvp1680 bacteria and that
TTSS1 was functional in this strain.
Analysis of the ability of this Δvp1680 strain to induce
MAPK activation in the Caco-2 and HeLa cells was per-
formed by immunoblotting of the extracted proteins
with anti-phospho-JNK, -p38 and -ERK antibodies
(Figure 2). In Caco-2 cells, the Δvp1680 strain lacked
the ability to activate p38 and JNK to the extent seen
with the WT, indicating that VP1680 was the TTSS1
effector required for activation of these two MAPK.
While reduced ERK activation was observed with the
Δvp1680 strain as compared to the WT, a conclusive
resolution could not be drawn, due to the low overall
fold increase in ERK activation. In HeLa cells a more
pronounced decreased phosphorylation of ERK occurred
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Page 7 of 16in response to Δvp1680. In contrast, VP1680 was only
partly responsible for activation of p38 and JNK, as just
a slight reduction in phosphorylation was seen in cells
co-incubated with the V. parahaemolyticus strain lack-
ing this effector as compared to WT bacteria. As activa-
tion of the MAPK is not abolished when VP1680 is
non-functional, this suggests that there is an alternative
TTSS1 effector that can activate MAPK in HeLa cells,
but not in Caco-2 cells
Our results show that VP1680 is necessary for the acti-
vation of JNK and p38 in Caco-2 cells and that JNK is
involved in the VP1680-dependent cytotoxicity of V. para-
haemolyticus. These data together demonstrate that
VP1680 is required for the ability of V. parahaemolyticus
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activation of JNK.
Both TTSS are involved in modulation of IL-8 secretion by
intestinal epithelial cells in response to V.
parahaemolyticus
In response to pathogenic bacteria, intestinal epithelial
cells produce a number of pro-inflammatory cytokines
and chemokines, such as IL-8 which attracts neutrophils
to the site of infection and can lead to inflammatory
responses that may facilitate bacterial infection and
colonisation [39-41]. The MAPK are key players in the
signal transduction pathways that lead to IL-8 secretion.
Therefore we tested the ability of V. parahaemolyticus
to induce IL-8 secretion from Caco-2 cells and investi-
gated the role of the TTSS and the MAPK in this event.
The V. parahaemolyticus strains carrying mutations in
each of the two TTSS were co-incubated with Caco-2
cells and the IL-8 response was measured by RT-PCR
and ELISA (Figure 5A and 5C respectively). IL-1b was
added as a positive control for the induction of IL-8
secretion. RNA extracts were prepared after 2 h of co-
incubation while the supernatant used for ELISA detec-
tion of IL-8 was recovered 24 h later.
The RT-PCR results showed that IL-8 transcription
was strongly activated by the IL-1b positive control and
was induced to a lower extent by WT V. parahaemolyti-
cus, while there was no increase of transcription
observed using the heat-killed V. parahaemolyticus
(Figure 5A). This result shows that live V. parahaemoly-
ticus actively induces IL-8 transcription. The ΔvscN1
and Δvp1680 strains induced similar levels of IL-8 tran-
scription in the Caco-2 cells to the WT V. parahaemoly-
ticus, while the ΔvscN2 strain induced a high level of IL-
8 transcription (more than 4-fold the level of IL-8 tran-
script induced by the WT V. parahaemolyticus). This
suggests that after 2 h of co-incubation TTSS1 is not
involved in IL-8 mRNA production by the Caco-2 cells,
while TTSS2 is involved in the inhibition of the IL-8
transcription.
The ELISA results show that 24 h after co-incubation,
WT V. parahaemolyticus is a powerful activator of IL-8
secretion by Caco-2 cells, as there was a 15-fold increase
in IL-8 concentrations after WT V. parahaemolyticus
co-incubation in comparison to untreated Caco-2 cells
(Figure 5C). Similar IL-8 concentrations were detected
with the Caco-2 cells alone and in the presence of heat-
killed WT V. parahaemolyticus. A dramatic reduction of
IL-8 secretion was observed in response to ΔvscN1,
showing an involvement of the TTSS1 apparatus in the
activation of IL-8 secretion. Moreover, the use of the
Δvp1680 strain showed an intermediate level of IL-8
secretion when compared to the WT and ΔvscN1
strains, suggesting that the effector protein VP1680 is
involved in the IL-8 secretion activation by the Caco-2
cells in response to the bacteria but it is not the only
TTSS1 effector responsible for this activation. With the
ΔvscN2 strain there was a higher level of IL-8 secretion
by the Caco-2 cells than that observed with the WT V.
parahaemolyticus, suggesting that TTSS2 is involved in
the inhibition of the IL-8 secretion by the Caco-2 cells
in response to the bacteria 24 h after the addition of the
bacteria.
These results demonstrate that V. parahaemolyticus
actively induces the transcription and production of IL-
8 by the host cell. TTSS1 is involved in the activation of
IL-8 production by the host while TTSS2 is involved in
its inhibition. Moreover, we have demonstrated that the
TTSS1 effector VP1680 is involved in the stimulation of
IL-8 secretion by the host.
The ERK signalling pathway is activated by V.
parahaemolyticus and leads to IL-8 secretion by intestinal
epithelial cells
In order to obtain a better overview of the signalling
pathways leading to IL-8 activation in response to
V. parahaemolyticus, the pharmacologic inhibitors of
the MAPK signalling pathways were added during
co-incubation and IL-8 secretion was quantified by
ELISA (Figure 6). Addition of the inhibitors SB203580
and SP600125 had no influence on the level of IL-8
secreted by the Caco-2 cells co-incubated with WT V.
parahaemolyticus, while the use of the ERK inhibitor
PD98059 led to a significant decrease in the concentra-
tion of secreted IL-8. In fact a decrease of about 25%
was seen in the IL-8 level secreted by the Caco-2 cells
co-incubated with the WT V. parahaemolyticus when
the cells have been pre-treated with PD98059. This
result suggests that the inhibition of ERK signalling
leads to inhibition of the resulting IL-8 secretion level.
ERK signalling is a major signalling pathway activated
by the WT V. parahaemolyticus and leads to the activa-
tion of IL-8 secretion by the eukaryotic cells.
Discussion
The results of this study demonstrate that V. parahae-
molyticus causes activation of MAPK in human intest-
inal epithelial cells and that this activation is linked to
the cellular responses elicited by this bacterium.
V. parahaemolyticus induced activation of each of the
MAPK - JNK, p38 and ERK - in Caco-2 and HeLa cells
(Figure 1 and 2). A mutant strain with a non-functional
TTSS1 (ΔvscN1) did not cause MAPK activation, pro-
viding the first evidence that TTSS1 is responsible for
the activation of MAPK in epithelial cells in response to
infection with V. parahaemolyticus (Figure 2). While the
role of TTSS1 in ERK activation was difficult to observe
in Caco-2 cells, differences in the activation of ERK in
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Page 10 of 16HeLa cells co-incubated with WT compared to ΔvscN1
bacteria were clearly evident. V. parahaemolyticus there-
fore now joins a select group of gram-negative patho-
gens that use TTSS effectors to activate MAPK
signalling to promote pathogen infection. Given the
important role MAPK play in controlling host innate
immune responses and cell growth, differentiation and
death, they are commendable targets for pathogenic
effectors. While several pathogens use their TTSS to
inhibit MAPK activation [34,35,42,43], others activate
them. For example, the inflammatory responses induced
by the TTSS effectors of Salmonella typhimurium are
related to activation of all MAPK, especially p38 which
induces IL-8 secretion from epithelial cells [39], and
Burkholderia pseudomallei utilizes its TTSS to induce
IL-8 secretion and to increase bacterial internalization
via activation of p38 and JNK in epithelial cells [44].
Several Vibrio spp. manipulate MAPK signalling path-
ways to induce host cell death or disturb the host
response to infection [40,45-49]. Vibrio vulnificus trig-
gers phosphorylation of p38 and ERK via Reactive Oxy-
gen Species in peripheral blood mononuclear cells
thereby inducing host cell death [46]. The CtxB cholera
toxin from Vibrio cholerae down-regulates p38 and JNK
activation in macrophages leading to suppression of
production of TNFa and other pro-inflammatory cyto-
kines [40,47]. Additionally Flagellin A from V. cholerae
contributes to IL-8 secretion from epithelial cells
through TLR5 and activation of p38, ERK and JNK [48].
Despite the fact that V. parahaemolyticus possesses fla-
gellin proteins similar to those of V. cholerae [49], cells
co-incubated with heat-killed V. parahaemolyticus did
not exhibit MAPK phosphorylation (Figure 1), suggest-
ing an absence of TLR5 recognition of flagellin. TLR5 is
activated by dissociated flagellin monomers and the
sheathed Vibrio flagella present on intact bacteria have a
limited ability to trigger host innate immunity [50]. In
our studies bacteria were washed before addition to the
cells and were treated at a temperature unlikely to dis-
sociate flagellin monomers [50], thereby minimising the
amounts of flagellin monomers present to trigger TLR5.
The results obtained from LDH assays, MTT assays
and fluorochrome staining confirmed that the TTSS1 of
V. parahaemolyticus is essential for the cytotoxicity of
this bacterium towards epithelial cells (Figure 3).
Furthermore these results show that there was no cell
death detected prior to the 2 h time point, by which
time MAPK activation was observed. It has been
reported that undifferentiated Caco-2 cells are more
susceptible than other cell types (e.g. HeLa cells) to a
TTSS2-mediated delayed cytotoxicity [15,51]. While
TTSS1 was required for cytotoxicity during the first 4 h
of co-incubation, there was little difference in the
levels of cytotoxicity observed with ΔTTSS1 bacteria
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tions were performed for 6 h [51]. This delayed cell
death was attributed to the VopT TTSS2 effector [51].
Delayed cytotoxicity was also observed by Burdette et al.
in HeLa cells infected with ΔTTSS2/Δvp1680 bacteria
[29]. The mechanism of this delayed cytotoxicity is
unknown. With extended co-incubations of 8 h we too
saw delayed TTSS1- and VP1680-independent cytotoxi-
city with differentiated Caco-2 cells (unpublished data
Finn and Boyd). The delayed cytotoxicity was the not
the subject of this study.
The VP1680 effector protein is responsible for the
TTSS1-dependent autophagic cytotoxicity against HeLa
cells [25,29]. Our results demonstrated that VP1680 is
required for the induction of JNK and p38 phosphory-
lation in Caco-2 cells (Figure 2) and that JNK and
ERK, but not p38, are involved in the TTSS1-depen-
dent cytotoxicity (Figure 4). Each of the 3 MAPK has
been proposed to regulate autophagy and/or autopha-
gic cell death, though the role and relative importance
of each one seems to be dependent on cell type and
on the induction stimulus [52-54]. The activation of
JNK and ERK by VP1680 seems to be important for
the cytotoxicity of V. parahaemolyticus towards epithe-
lial cells, whereas phosphorylation of p38 by this effec-
tor protein plays a different role in modification of
host cell behaviour that remains to be defined. In
HeLa cells VP1680 is responsible for the activation of
ERK, but plays a lesser role in the activation of JNK
and p38 than it does in Caco-2 cells (Figure 2). As
activation of all three MAPK in HeLa cells in response
to V. parahaemolyticus is TTSS1-dependent, but not
VP1680-dependent, this points to the existence of an
additional MAPK-activating TTSS1 effector that acts
in this cell line. Since VP1680 is the principal TTSS1
effector activating MAPK in Caco-2 cells, this would
suggest differing sensitivities of cell lines to the TTSS
effectors.
The observation that VP1680 induces phosphorylation
of all 3 MAPK raises the possibility that this protein
may not target the MAPK directly, but may trigger an
upstream kinase. In contrast to VP1680, the VopA
TTSS2 effector has been found to inhibit MAPK in
macrophages by acetylating the upstream MAPK Kinase
(MKK) [18,30]. It is important to note that the VopA
studies were performed with transfected eukaryotic cells
that expressed VopA heterologously, whereas the cur-
rent study assessed MAPK activation by intact V. para-
haemolyticus. From our studies during co-incubation of
V. parahaemolyticus with Caco-2 cells it appears that
the MAPK activation of VP1680 is dominant over the
inhibitory effect of VopA. V. parahaemolyticus may co-
ordinately regulate both TTSS to achieve appropriate
control of host responses.
V. parahaemolyticus induced IL-8 secretion in an
active manner as a result of delivery of the TTSS effec-
tor proteins into host cells (Figure 5). It appears that
there may be a balance between TTSS1 and TTSS2 of
V. parahaemolyticus where TTSS1 is involved in the
activation of IL-8 production by the host while TTSS2
is involved in its inhibition. This correlates with the
opposing functions of the TTSS1 effector VP1680 and
the TTSS2 effector VopA in activating and inhibiting
MAPK phosphorylation. Interestingly, the TTSS1 effec-
tor VP1680 mutant (Δvp1680) induced intermediate
amounts of IL-8, suggesting an involvement of this pro-
tein in stimulating production of this chemokine, but
not an absolute requirement (Figure 5). Similarly the
inhibitory studies revealed that V. parahaemolyticus
induces secretion of IL-8 partly via modulation of the
ERK signalling pathway (Figure 6). The complex effect
of both TTSS of V. parahaemolyticus on the host
immune defence machinery illustrates the powerful
tools the bacteria possess to gain maximum advantage
from the host environment.
Conclusions
A better understanding of the virulence mechanisms of
V. parahaemolyticus is imperative for better diagnosis,
treatment and prevention of gastrointestinal infections.
The findings presented here provide new insights into
the roles of TTSS1 and TTSS2 in modulating epithelial
cell responses to infection. V. parahaemolyticus induced
JNK, ERK and p38 activation in human epithelial cells.
TTSS1, and the TTSS1 effector VP1680, were of key
importance for sabotaging normal MAPK cellular pro-
cesses and disrupting host responses to infection.
MAPK activation was associated with the cytotoxic
effects exerted by the bacterium and with the induction
of IL-8 secretion. The diverse roles of MAPK signalling
during infection with V. parahaemolyticus indicate it is
a significant mechanism to promote virulence.
Methods
Cells and reagents
V. parahaemolyticus RIMD2210633, O3:K6 serotype
(wild type, WT) [12] was used for the construction of
deletion mutants as well as to perform all experiments.
The following bacterial mutants were used: VVN1
(ΔTTSS1 with non-functional TTSS1 due to deletion in
the vscN1 gene encoding the ATPase for TTSS1), VVN2
(ΔTTSS2 with non-functional TTSS2 due to deletion in
the vscN2 gene encoding the ATPase for TTSS2) and
VVE1 (Δvp1680). Bacteria were cultured at 37°C in
Luria-Bertani medium supplemented with 3% (w/v)
NaCl (LBN) and the addition of 1.5% (w/v) agar where
appropriate. The human epithelial intestinal Caco-2 and
cervical HeLa cell lines were obtained from the DSMZ
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tures). Caco-2 cells were grown as a monolayer in
Dulbecco’s Modified Eagle’s Medium (DMEM) supple-
mented with 2 mM L-glutamine (Gibco), Pen-Strep (100
units/ml penicillin, 100 μg/ml streptomycin, (Gibco), 1%
non-essential amino acids (Gibco) and 20% (v/v) Foetal
Bovine Serum (Gibco) at 37°C, 5% CO2. All materials
used were purchased from Sigma, unless otherwise sta-
ted. Measurement of absorbance of samples in 96-well
plates was performed using a Tecan Sunrise and Magel-
lan software.
Construction of deletion mutant strains
Molecular biology techniques were performed according
to Sambrook and Russell [55]. PCR reagents were
obtained from Bioline, DNA purification kits and mole-
cular biology enzymes from Promega and oligonucleo-
tides from MWG/Eurofins. The standard PCR reaction
volume was 50 μl, containing 50 ng template DNA, 400
nM each primer and 1× Polymerase Mix (Bioline). 1
st
round PCR reactions in the overlap extension method
were performed with Accuzyme polymerase and the
standard PCR conditions were 3 min at 95°C (1 cycle),
30 sec at 95°C, 30 sec at 58°C, 2 min/kb at 68°C (30
cycles), 5 min at 68°C (1 cycle). Other PCR reactions
were performed with Taq polymerase, and an extension
time and temperature of 30 sec/kb and 72°C, respec-
tively. In some cases the annealing temperature was
optimised for a specific PCR reaction.
In-frame deletion mutations were constructed in the
vscN genes of each of the V. parahaemolyticus TTSS in
order to inactivate each of these secretion systems inde-
pendently. As the vscN gene encodes the ATPase that
powers the secretion process, mutation of this gene
eliminates secretion. The TTSS1-associated VscN1 is
encoded by vp1668 and TTSS2-associated VscN2 is
encoded by vpa1338. Each mutant allele was con-
structed by overlap PCR. The primers PrAB49 (AACGC
GAACGCCACCGTC), PrAB50 (TCTGCTA CGCGCTG
CTTGAGC), PrAB51 (ACTTGCAGACAA CTCTCCA
ACGCGTAC) and PrAB52 (GGAGAGTT GTCTGCA
AGTCGAGTGATG) were used for generation of the
vscN1Δ142-1065 allele encoding VscN1Δ51-355. Primers
PrAB45 (GCCATCAGGTCAAGTGCAAG), PrAB47
(TCTATAGCTATTTCACCGCGGATTCTC), PrAB48
(CGGTGAAATAGCTATAGAACGCTACCC) and PrA
B59 (GTCTACCGTATCTCGAATGAATAG CG) were
employed to generate the vscN2Δ132-1154 allele encoding
VscN2Δ45-385.T h eP C Rp r o d u c t sw e r ec l o n e di n t o
pCR2.1 by TA topoisomerase cloning according to the
manufacturer’s instructions (Invitrogen). The alleles
were then transferred into the suicide vector pDS132
[56] by extraction with the restriction enzymes SacI and
XbaI, for vscN1 and vscN2 respectively, followed by
ligation into the corresponding restriction sites of
pDS132. This resulted in plasmid pABGA11 containing
the vscN1Δ142-1065 allele and pABGA13 containing the
vscN2Δ132-1154 allele.
Triparental conjugations with Escherichia coli
CC118lpir(pEVS104) [57] were performed to introduce
pABGA11 and pABGA13 into V. parahaemolyticus
RIMD2210633 and selection of first recombinants was
performed on LBN agar containing 5 μg/ml chloram-
phenicol. Subsequently second recombinants were
selected on LBN agar containing 10% sucrose and then
screened by PCR with primers PrAB49 and PrAB50 for
vscN1 and primers PrAB45 and PrAB59 for vscN2.B a c -
teria that contained the gene of the expected shortened
length were designated VVN1 for the vscn1 mutant
strain and VVN2 for the vscn2 mutant strain.
V. parahaemolyticus VVE1 containing a mutated
vp1680 gene was constructed in a similar manner utilis-
ing primers PrAB88 (AAACATGGCACTGTAA GCG
TCG), PrAB89 (GGTTAGCGCACTCAAGCAAAT GC
TTGGC), PrAB91 (GCGCGTAAGAGGCTTAGA GC)
and PrAB92 (GCTTGAGTGCGCTAACCTAAGC AAA
CTTG) to remove nucleotides 161-1120. In addition a
TAA stop codon was introduced at codon 51 (altered
nucleotide shown in italics) so that a truncated protein
would be produced.
V. parahaemolyticus and epithelial cell line co-incubation
studies
All experiments with Caco-2 cells were carried out on
differentiated cells obtained by culturing of the cells for
7 days (3 days post-confluency). HeLa cells were seeded
the day prior to the co-incubation. During co-incuba-
tions with bacteria the cells were maintained in growth
medium free of Pen-Strep antibiotics. Bacteria were cul-
tured to obtain cells in mid-log phase of growth and
then washed with PBS. Monolayers were co-incubated
with WT V. parahaemolyticus and constructed deletion
mutants at an MOI of 10. After the co-incubation per-
iod samples were taken for analysis. Preliminary experi-
ments were performed with a range of MOI. Cells
infected with an MOI of 10 displayed reproducible and
reliable MAPK activation and cell lysis data and so this
MOI was selected for use throughout these studies. In
some experiments MAPK inhibitors were added to the
cells 2 h prior to the addition of the bacteria at these
concentrations: 15 μM SP600125, 5 μM SB203580 and
40 μM PD184352.
Lactate Dehydrogenase (LDH) assay
The Caco-2 cells were co-incubated with bacteria for 1,
2, 3 or 4 h. The LDH assay was performed using the
CytoTox 96 Non-Radioactive Cytotoxicity Assay kit
(Promega) according to the manufacturer’s instructions.
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provided by manufacturer and expressed as percentage
cell lysis.
MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide) assay
The Caco-2 cells were co-incubated with bacteria for 1,
2, 3 or 4 h. The cells were washed and resuspended first
in fresh complete medium containing 50 μg/ml genta-
m i c i nf o r1ha n dt h e n5μg/ml gentamicin for 20 h to
kill extracellular bacteria. Monolayers were then incu-
bated in MTT solution (5 mg/ml; 50 μl/well) for a
further 3 h. The medium containing MTT was removed
and the insoluble violet formazan crystals were dissolved
in dimethyl sulfoxide. The absorbance was measured at
l550-590 nm. Cell viability was calculated as a percen-
tage of the untreated Caco-2 cells.
Phase contrast light microscopy and fluorescent
microscopy
The Caco-2 cells were co-incubated with bacteria for 2
and 4 h. After the co-incubation monolayers were
washed and imaged by phase contrast light microscopy
on a Leica DM IL inverted microscope fitted with a
DFC420C digital camera using LAS software. For fluor-
escent microscopy after the co-incubation periods all
detached and adherent Caco-2 cells were harvested,
washed and stained with 230 μM propidium iodide/300
μM Hoechst 33342 for 5-10 min. Three hundred Caco-2
cells were analyzed and scored under the Olympus
fluorescent microscope IX51 using Cell software and the
DAPI filter (l488 nm, Hoechst 33342 and PI positive)
and the TxRed filter (l520 nm, PI positive only).
Immunoblotting
Following co-incubation with bacteria the epithelial cells
were washed in PBS and lysed with Laemmli sample buf-
fer. Samples were resolved on Sodium Dodecyl Sulphate
Polyacrylamide Gel Electrophoresis (SDS-PAGE) and
transferred to nitrocellulose. The membranes were incu-
bated first with the following primary rabbit antibodies -
phospho-SAPK/JNK (Thr183/Tyr185) mAb, phospho-
p42/44(Thr202/Thr204) pAb, phospho-p38 (Thr180/
Tyr182) pAb obtained from Cell Signalling Technology
Inc - and then with Horse Radish Peroxidase (HRP)-con-
jugated anti-rabbit IgG antibody (Jackson ImmunoRe-
seach Laboratories). Blots were developed using the
enhanced chemiluminescence detection method. Non-
saturated film exposures were digitized by flatbed scan-
ning and quantified by densitometry. To detect total level
of protein the membrane was re-probed with corre-
sponding primary antibody: pan-JNK, p38 or p42/44
mouse mAb (R&D Systems).
Cell-Based Monodansylcadaverine (MDC) Assay
Caco-2 cells were seeded 24 h prior to the addition of
the chemical MAPK inhibitors. Following 2 h incuba-
tion, WT V. parahaemolyticus was added to each well
for 3 h. The MDC assay was performed using the
Autophagy/Cytotoxicity Dual Staining Kit (Cayman Che-
mical Company) according to the manufacturer’s
instructions. Incubation steps were carried out in the
dark. All centrifuge steps were omitted. The results
obtained were analyzed using a Leica DMI3000B micro-
scope and Leica application suite V3.3.0 software.
ELISA
After co-incubation of the differentiated Caco-2 mono-
layers with V. parahaemolyticus,o r2 0hg/ml IL-1b as
a positive control, IL-8 in the growth medium was
detected by ELISA using the Bender Medsystem
human IL-8 ELISA Kit following the manufacturer’s
instructions. This detection of IL-8 was performed 6 h
and 24 h after a 2 h co-incubation period which had
been stopped by three successive washes with PBS and
the addition of complete growth medium containing
50 μg/ml gentamicin.
RNA extraction and reverse transcription PCR
RNA was extracted by the Trizol method (Invitrogen).
The RNA preparations were treated with DNAse I (Invi-
trogen) to remove contaminating DNA and reverse-
transcribed by use of an M-MLV reverse transcriptase
(Invitrogen). Then PCR was performed for 30 cycles at
95°C, 30 s; 55°C, 30 s; 72°C, 30 s with a final amplifica-
tion for 5 min at 72°C. The IL-8 gene was amplified
using the primers IL-8 Forward GTTCCACTGTG
CCTTGGTTT and IL-8 Reverse ACACAGCTGG
CAATGACAAG, and the b-actin gene as control was
amplified using b-actin Forward AAATCTGGCACCA
CACCTTC and b-actin Reverse AGTGGGGTGGCTTT
TAGGAT. Visualisation of the PCR products was per-
formed following agarose gel electrophoresis using
SYBRsafe (Invitrogen) and a UV light source on a G:Box
from SynGene and using the software GeneSnap from
Syngene. Quantification was performed by comparing
the intensity of the PCR product bands to the Quantita-
tive Hyperladder I (Bioline) as a reference and then
determining the ratio between IL-8 and b-actin PCR
products in each sample.
Statistical analysis
Significance of the differences between groups was
assessed using one way analysis of variance (ANOVA)
with post-hoc Tukey-Kramer multiple comparisons test
using GraphPad Instat software. p < 0.05 were consid-
ered statistically significant.
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Additional file 1: Figure S1: Morphological changes induced in
Caco-2 cells by V. parahaemolyticus Δvp1680. Caco-2 cells were co-
incubated with V. parahaemolyticus WT, ΔvscN1, ΔvscN2 or Δvp1680 for 4
h. Morphological changes of the cells were then observed by phase
contrast light microscope (magnification 400×).
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